HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitsune Tanimoto Selected Research

Neutropenia

8/2012Efficacy and safety of doripenem for sepsis with neutropenia in Japanese patients with hematologic diseases.
3/2012Efficacy and safety of micafungin as an empirical antifungal therapy for suspected fungal infection in neutropenic patients with hematological disorders.
5/2009Febrile neutropenia and periodontitis: lessons from a case periodontal treatment in the intervals between chemotherapy cycles for leukemia reduced febrile neutropenia.
8/2006A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancer.
7/2004Phase I study of docetaxel and irinotecan in patients with advanced non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitsune Tanimoto Research Topics

Disease

77Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2020 - 03/2002
72Neoplasms (Cancer)
02/2023 - 03/2002
62Lung Neoplasms (Lung Cancer)
10/2017 - 03/2002
26Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2016 - 05/2002
19Inflammation (Inflammations)
01/2019 - 04/2005
15Leukemia
01/2017 - 04/2002
14Graft vs Host Disease (Graft-Versus-Host Disease)
02/2018 - 04/2002
13Lymphoma (Lymphomas)
10/2014 - 04/2002
11Disease Progression
11/2017 - 05/2005
11Respiratory Hypersensitivity
06/2016 - 04/2005
10Interstitial Lung Diseases (Interstitial Lung Disease)
06/2010 - 03/2003
10Adenocarcinoma
01/2009 - 03/2002
9Neoplasm Metastasis (Metastasis)
07/2020 - 03/2002
9Asthma (Bronchial Asthma)
12/2017 - 09/2006
9BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2017 - 01/2003
8Bronchiolitis Obliterans Syndrome
01/2017 - 02/2007
8Febrile Neutropenia
01/2015 - 01/2004
8Infections
05/2014 - 08/2002
7Hematologic Neoplasms (Hematological Malignancy)
08/2017 - 01/2004
7Fibrosis (Cirrhosis)
01/2012 - 03/2003
6Carcinogenesis
02/2023 - 09/2008
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 06/2004
6Pneumonia (Pneumonitis)
11/2016 - 05/2005
6Malignant Pleural Effusion
10/2014 - 02/2007
5B-Cell Lymphoma (Lymphoma, B Cell)
09/2021 - 12/2002
5Emphysema
01/2019 - 01/2013
5Pleural Effusion (Pleural Effusions)
06/2017 - 08/2011
5Fever (Fevers)
08/2016 - 08/2002
5Adenocarcinoma of Lung
10/2014 - 07/2005
5Neutropenia
08/2012 - 07/2004
4Body Weight (Weight, Body)
02/2023 - 11/2002
4Carcinoma (Carcinomatosis)
01/2017 - 10/2002
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2017 - 01/2003
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2015 - 04/2009
4Hyperplasia
07/2014 - 04/2005
4Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
05/2014 - 12/2003
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2011 - 03/2002
3Brain Neoplasms (Brain Tumor)
07/2020 - 11/2004
3Pulmonary Emphysema
01/2019 - 01/2013
3T-Cell Lymphoma (Lymphoma, T Cell)
12/2017 - 04/2014

Drug/Important Bio-Agent (IBA)

43Gefitinib (Iressa)FDA Link
11/2016 - 04/2003
38ErbB Receptors (EGF Receptor)IBA
07/2020 - 01/2004
37Cisplatin (Platino)FDA LinkGeneric
02/2023 - 03/2002
26Tyrosine Kinase InhibitorsIBA
11/2017 - 01/2004
15Irinotecan (Camptosar)FDA LinkGeneric
07/2012 - 01/2003
11Docetaxel (Taxotere)FDA Link
04/2012 - 07/2004
10Doxorubicin (Adriamycin)FDA LinkGeneric
12/2017 - 01/2003
10AntigensIBA
01/2017 - 08/2002
9Carboplatin (JM8)FDA LinkGeneric
10/2017 - 05/2002
9CytokinesIBA
06/2016 - 03/2002
8Etoposide (VP 16)FDA LinkGeneric
12/2017 - 05/2002
8OvalbuminIBA
12/2017 - 09/2006
8Imatinib Mesylate (Gleevec)FDA Link
06/2017 - 05/2007
8Proteins (Proteins, Gene)FDA Link
06/2016 - 11/2002
8Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2016 - 01/2010
7PlatinumIBA
01/2017 - 06/2002
7AllergensIBA
01/2014 - 09/2006
6Rituximab (Mabthera)FDA Link
09/2021 - 11/2007
6Pancreatic Elastase (Elastase)IBA
01/2019 - 01/2013
6Indicators and Reagents (Reagents)IBA
11/2017 - 10/2002
6IfosfamideFDA LinkGeneric
05/2009 - 03/2002
6DNA (Deoxyribonucleic Acid)IBA
09/2008 - 08/2003
6Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
07/2007 - 10/2002
6Interleukin-8 (Interleukin 8)IBA
07/2007 - 01/2003
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2017 - 06/2007
5Topotecan (Hycamtin)FDA LinkGeneric
10/2016 - 06/2006
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2016 - 09/2002
5Biomarkers (Surrogate Marker)IBA
01/2015 - 09/2008
5Messenger RNA (mRNA)IBA
07/2014 - 04/2002
5Paclitaxel (Taxol)FDA LinkGeneric
05/2014 - 07/2004
5amrubicinIBA
07/2012 - 05/2005
4Vincristine (Oncovin)FDA LinkGeneric
12/2017 - 05/2008
4Prednisone (Sone)FDA LinkGeneric
12/2017 - 01/2006
4Reactive Oxygen Species (Oxygen Radicals)IBA
03/2017 - 10/2002
4Bevacizumab (Avastin)FDA Link
01/2017 - 05/2013
4AfatinibIBA
01/2017 - 05/2013
4Interleukin-2 (IL2)IBA
01/2017 - 03/2002
4Phosphotransferases (Kinase)IBA
03/2016 - 01/2004
4ChemokinesIBA
04/2015 - 07/2005
4ParaffinIBA
09/2014 - 04/2009
4Anti-Bacterial Agents (Antibiotics)IBA
06/2014 - 01/2004
4Vindesine (Vindesin)IBA
06/2011 - 03/2002
4Fluorouracil (Carac)FDA LinkGeneric
01/2011 - 03/2003
4GemcitabineFDA Link
04/2008 - 03/2006
3Chemotactic FactorsIBA
01/2019 - 01/2003
3Interleukin-17 (Interleukin 17)IBA
01/2019 - 01/2013
3Tacrolimus (Prograf)FDA LinkGeneric
02/2018 - 06/2006
3Anaplastic Lymphoma KinaseIBA
12/2017 - 03/2016

Therapy/Procedure

63Drug Therapy (Chemotherapy)
09/2021 - 03/2002
48Therapeutics
01/2023 - 08/2002
13Hematopoietic Stem Cell Transplantation
01/2017 - 04/2002
12Radiotherapy
10/2016 - 05/2002
12Cell Transplantation
10/2016 - 06/2004
10Transplantation
08/2017 - 09/2003
9Chemoradiotherapy
03/2018 - 12/2003
9Combination Drug Therapy (Combination Chemotherapy)
01/2012 - 03/2002
7Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2014 - 01/2005
5Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
05/2006 - 08/2002
4Aftercare (After-Treatment)
02/2022 - 10/2006
4Adjuvant Chemotherapy
01/2012 - 10/2004